Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy (NCT06814184) | Clinical Trial Compass
RecruitingNot Applicable
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin Therapy
United States60 participantsStarted 2026-04-01
Plain-language summary
This 12-month pilot tests a nurse-led, app-based intervention to improve diabetes self-management for Medicaid patients. It includes MyChart messaging to give education, phone help on problem-solving with clinicians, and using a diabetes app to track data. The study aims to enhance self-management behaviors through health technology.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* A1C \>7 for age 18-64, A1C\>8 for age 65 or older within 12 months prior baseline
* A1C\>7 for age 18-64, A1c\>8 for age 65 or older at baseline
* Medicaid recipient or dual Medicaid and Medicare recipient
* Age 18 or older
* Type 2 diabetes
* On insulin therapy
* Owning and using Android or iOS smartphone for at least 6 months
* English proficiency
* Adequate vision to read text messages on their current smartphone
* Smartphone use proficiency. Smartphone proficiency will be self-reported and determined by telephone as the ability to use a smartphone in ways other than emailing, texting, and making phone calls.
Exclusion Criteria:
* Pregnancy
* Patients with cognitive impairment who will be screened with the Six-Item Screener to Identify Cognitive Impairment Among Potential Research Subjects.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Glycemic control: glycated hemoglobin AIC
Timeframe: baseline, 3, 6, 9, and 12 months
2
Glycemic control - the rate of pre-prandial blood glucose readings in target range
Timeframe: baseline, 3, 6, 9, and 12 months
3
Glycemic control - the rate of peak postprandial blood glucose reading in target range
Timeframe: baseline, 3, 6, 9, and 12 months
Trial details
NCT IDNCT06814184
SponsorRutgers, The State University of New Jersey